Angiodynamic Inc
ANGO
Get informed when a big investor buys or sells
+ FollowMarket Cap$611.31M
Close$
$3.89
74.1% downside
Current Fair Value
74.1% downsideOvervalued by 74.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $611.31 Million |
|---|---|
| Enterprise Value | $557.44 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.88 |
| Beta | 0.34 |
| Outstanding Shares | 41,526,000 |
Return
| Return on Equity | -21.51% |
|---|---|
| Return on Assets | -13.75% |
| Return on Invested Capital | -13.61% |
Valuation & Multiples
| P/E Ratio | -16.81 |
|---|---|
| PEG | -18.99 |
| Price to Sales | 2.15 |
| Price to Book Ratio | 3.76 |
| Enterprise Value to Revenue | 1.74 |
| Enterprise Value to EBIT | -21.29 |
| Enterprise Value to Net Income | -16 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 21, 2026
EPS Estimate
$-0.11
Average shareholder expectationRevenue Estimate
$80.24 M
Average shareholder expectationNext Earnings Call
Expected Date
October 1, 2026
EPS Estimate
$-0.09
Average shareholder expectationRevenue Estimate
$80.50 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 34.69% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 1.56%▼ 91.08% |
|---|---|
| Total Invested | $8.45M▼ 98.07% |
| Investors Holding | 27▼ 124.00% |
ESG Score
No data
About Angiodynamic Inc
CEO: James Clemmer AngioDynamics, Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, peripheral vascular disease, and oncology. AngioDynamics' diverse product lines in...